Integra LifeSciences Holdings

IART.US
Healthcare · Medical Devices
19.76
+0.23 (+1.18%)
USD · NASDAQ

Company Information

Company Name
Integra LifeSciences Holdings
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US4579852082
CIK: 0000917520
CUSIP: 457985109
Currency: USD
Full Time Employees: 4,427
Phone: 609 275 0500
Fiscal Year End: December
IPO Date: Aug 16, 1995
Description:

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Address:

1100 Campus Road, Princeton, NJ, United States, 08540

People

Directors & Officers

Name Title Year Born
Dr. Stuart M. Essig Ph.D. CEO, President & Chairman 1962
Ms. Lea Daniels Knight Executive VP & CFO 1972
Mr. Robert T. Davis Jr. Executive Vice President of Tissue Reconstruction and Distributed Technologies 1959
Mr. Michael J. McBreen Executive VP & Chief Commercial Officer 1966
Mr. Harvinder Pal Singh Executive VP & President of International Business 1966
Mr. Jeffrey A. Mosebrook Senior VP of Finance & Principal Accounting Officer 1976
Mr. Teshtar Elavia Corporate VP & Chief Technology Officer NA
Christopher Ward Senior Director of Investor Relations NA
Mr. Michael D. Hutchinson Executive VP, Chief Legal Officer & Secretary 1971
Laurene Isip Vice President of Global Corporate Communications & Public Relations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 05, 2025 Jeffrey A Graves N/A Purchase 9.00K $11.35 $102.15K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 10.32M Mar 31, 2026 13.26% $0.00 -0.28%
Rubric Capital Management LP 7.75M Mar 31, 2026 9.97% $0.77 0.00%
Vanguard Group Inc 7.21M Dec 31, 2025 9.27% $0.00 -2.28%
Paradigm Capital Management, Inc. 4.01M Mar 31, 2026 5.16% $1.45 50.57%
Vanguard Portfolio Management, LLC 3.69M Mar 31, 2026 4.74% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 3.58M Mar 31, 2026 4.61% $0.00 -6.88%
Fuller & Thaler Asset Management Inc 3.53M Mar 31, 2026 4.54% $0.11 -51.47%
Amvescap Plc. 3.49M Mar 31, 2026 4.48% $0.00 -1.06%
Vanguard Capital Management, LLC 2.89M Mar 31, 2026 3.72% $0.00 0.00%
State Street Corp 2.89M Mar 31, 2026 3.71% $0.00 2.63%
Dimensional Fund Advisors, Inc. 2.77M Mar 31, 2026 3.57% $0.01 -10.13%
Neuberger Berman Group LLC 2.12M Mar 31, 2026 2.72% $0.02 1.83%
The Goldman Sachs Group Inc 1.88M Mar 31, 2026 2.41% $0.00 30.72%
Geode Capital Management, LLC 1.66M Mar 31, 2026 2.13% $0.00 -1.60%
Charles Schwab Investment Management Inc 1.61M Mar 31, 2026 2.07% $0.00 3.35%
Bank of America Corp 1.41M Mar 31, 2026 1.82% $0.00 71.43%
Wellington Management Company LLP 1.30M Mar 31, 2026 1.67% $0.00 -3.93%
Systematic Financial Management LP 1.06M Mar 31, 2026 1.36% $0.23 -4.45%
Invenomic Capital Management, LP 1.01M Mar 31, 2026 1.30% $0.44 -4.23%
Glenmede Trust Co NA 984.69K Mar 31, 2026 1.27% $0.05 27.40%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 4.03M 5.18% ▲ 0.02% Jun 30, 2026
2 Invesco Small Cap Value A 3.39M 4.36% ▲ 0.00% May 31, 2026
3 FullerThaler Behavioral Small-Cap Value 3.12M 4.01% ▼ 0.14% May 31, 2026
4 Undiscovered Managers Behavioral Val L 2.93M 3.76% ▲ 0.00% May 31, 2026
5 Vanguard Total Stock Mkt Idx Inv 2.11M 2.71% ▲ 1.40% Jun 30, 2026
6 iShares Russell 2000 ETF 1.79M 2.30% ▲ 0.60% Jun 30, 2026
7 Vanguard Small Cap Index 1.51M 1.94% ▼ 0.57% Jun 30, 2026
8 Vanguard Small Cap Value Index Inv 960.85K 1.24% ▼ 2.16% Jun 30, 2026
9 Glenmede Small Cap Equity 859.00K 1.10% ▼ 3.56% Jun 30, 2026
10 Glenmede Small Cap Equity Adv 859.00K 1.10% ▼ 3.56% Jun 30, 2026

Financial Highlights

Market Cap: $1.52B
EBITDA: $308.30M
PEG Ratio: $0.71
Book Value: $13.40
Earnings/Share: $-6.38
Profit Margin: -30.15%
Operating Margin: 10.41%
ROA (TTM): 2.54%
ROE (TTM): -38.63%
Revenue (TTM): $1.64B
Revenue/Share (TTM): $21.42
Earnings Growth (YOY): 0.40%
Revenue Growth (YOY): 2.40%

Valuation Metrics

Enterprise Value: $3.31B
Trailing P/E: 0.00
Forward P/E: 8.05

Shares Statistics

Shares Outstanding: 77.80M
Shares Float: 58.70M
% Insiders: 1,429.30%
% Institutions: 10,015.20%
Short % Float: 11.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.64B
Cost of Goods Sold
adjust
$-790.01M
Gross Profit
subtotal
$845.23M
SG&A
adjust
$-699.70M
R&D
adjust
$-98.97M
Operating Income
subtotal
$68.32M
Other / Non-Operating Items
adjust
$-584.79M
Net Income
subtotal
$-516.47M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IART.US!